July 31, 2007
Implanted Stimulator to Prevent Seizures
Researchers at the Thomas Jefferson University Hospital Comprehensive Epilepsy Center are enrolling patients in a study of the Responsive Neurostimulator System (RNS) made by Neuropace to determine if it is effective in stemming seizures. The system contains a computer chip that detects seizures and then delivers electric current to the brain to stop them.
The goal is to be able to predict and prevent seizures before they start. The device would be targeted at people with uncontrolled epilepsy.
Details
The RNS neurostimulator is a programmable, battery powered, microprocessor-controlled device that delivers a short train of electrical pulses to the brain through implanted leads. In treating epilepsy, the RNS neurostimulator is designed to detect abnormal electrical activity in the brain and respond by delivering electrical stimulation to normalize brain activity before the patient experiences seizure symptoms. The neurostimulator is implanted in the cranium and connected to one or two leads that are implanted near the patient's seizure focus.
Thomas Jefferson University Hospital Press Release